Norges Bank
KYMR icon

Norges Bank’s Kymera Therapeutics KYMR Stock Holding History

Norges Bank’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.8M Buy
+757,246
New +$65.1M 0.01% 822
2026
Q1 		– Sell
-16,543
Closed -$1.29M – 752
2025
Q4 		$1.29M Buy
+16,543
New +$1.12M ﹤0.01% 1482
2025
Q3 		– Sell
-41,370
Closed -$1.81M – 840
2025
Q2 		$1.81M Sell
41,370
-8,327
-17% -$287K ﹤0.01% 1450
2025
Q1 		$1.36M Sell
49,697
-41,534
-46% -$1.51M ﹤0.01% 1581
2024
Q4 		$3.67M Hold
91,231
– – ﹤0.01% 1571
2024
Q3 		$4.32M Sell
91,231
-26,652
-23% -$1.18M ﹤0.01% 1557
2024
Q2 		$3.52M Hold
117,883
– – ﹤0.01% 1626
2024
Q1 		$4.74M Sell
117,883
-386,200
-77% -$13.8M ﹤0.01% 1629
2023
Q4 		$12.8M Buy
504,083
+386,200
+328% +$6.91M ﹤0.01% 1407
2023
Q3 		$1.64M Sell
117,883
-49,653
-30% -$998K ﹤0.01% 1850
2023
Q2 		$3.85M Hold
167,536
– – ﹤0.01% 1776
2023
Q1 		$4.96M Sell
167,536
-54,481
-25% -$1.76M ﹤0.01% 1759
2022
Q4 		$5.54M Hold
222,017
– – ﹤0.01% 1753
2022
Q3 		$4.83M Sell
222,017
-16,400
-7% -$432K ﹤0.01% 1772
2022
Q2 		$4.69M Buy
238,417
+99,726
+72% +$2.33M ﹤0.01% 1783
2022
Q1 		$5.87M Buy
138,691
+84,528
+156% +$3.57M ﹤0.01% 1840
2021
Q4 		$3.44M Hold
54,163
– – ﹤0.01% 1978
2021
Q3 		$3.18M Buy
54,163
+15,781
+41% +$915K ﹤0.01% 1989
2021
Q2 		$1.86M Buy
38,382
+16,352
+74% +$710K ﹤0.01% 2029
2021
Q1 		$856K Buy
22,030
+7,030
+47% +$423K ﹤0.01% 2063
2020
Q4 		$930K Hold
15,000
– – ﹤0.01% 2036
2020
Q3 		$485K Buy
+15,000
New +$458K ﹤0.01% 2082

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Norges Bank's KYMR Position: Q2 2026 in Review

Norges Bank opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 757,246 shares worth $86.8M. The stake represents 0.01% of the portfolio and ranks #822 among its holdings. This is a return to the name: Norges Bank previously reported a position in KYMR as recently as Q4 2025.

Norges Bank first reported a position in KYMR in Q3 2020 and has held it in 22 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Norges Bank held 757,246 shares of Kymera Therapeutics worth $86.8M as of Q2 2026.
  • Kymera Therapeutics was a new Norges Bank position in Q2 2026.
  • Kymera Therapeutics made up 0.01% of Norges Bank's portfolio in Q2 2026, its #822 holding.
  • Norges Bank first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.